Menu

• Ask a Health Expert about URETHRAL OBSTRUCTION
• Post Your Side Effect related to URETHRAL OBSTRUCTION
• URETHRAL OBSTRUCTION and FDA Warnings
• URETHRAL OBSTRUCTION in Patients Wiki
• Report URETHRAL OBSTRUCTION in Drug Side Effect Survey

URETHRAL OBSTRUCTION side effect

What is URETHRAL OBSTRUCTION ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Leukine Side Effects Report #5730144-3
Health Professional from UNITED STATES reported LEUKINE problem on May 05, 2008. Male patient, 64 years of age, weighting 275.6 lb, was diagnosed with prostate cancer and was treated with LEUKINE. After drug was administered, patient experienced the following problems/side effects: urethral obstruction, urethral stenosis, urinary incontinence, . LEUKINE dosage: unknown. Patient was hospitalized. Patient recovered.

Erbitux Side Effects Report #5736494-9
ERBITUX problem was reported by a Health Professional from UNITED STATES on May 08, 2008. Female patient, 46 years of age, weighting 103.6 lb, was diagnosed with adenocarcinoma of the cervix and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, urethral obstruction, . ERBITUX dosage: START DATE:29FEB08;CYCLE 1, D1 LOADING DOSE 400 MG/M2 IV. SUBSEQUENT DOSES: 250 MG/M2 IV ON D1 + D8. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Vesicare Side Effects Report #5368483-0
Health Professional from UNITED STATES reported VESICARE problem on June 04, 2007. Male patient, 32 years of age, weighting 154.3 lb, was diagnosed with neurogenic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: bladder neck obstruction, urethral obstruction, . VESICARE dosage: 10 MG, UID/QD, ORAL. Patient was hospitalized and became disabled. Patient recovered.

Vesicare Side Effects Report #5324447-4
VESICARE problem was reported by a Health Professional from UNITED KINGDOM on Apr 23, 2007. Male patient, 32 years of age, weighting 154.3 lb, was diagnosed with neurogenic bladder and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: catheter related complication, urethral obstruction, . VESICARE dosage: 10 MG, ORAL. Patient was hospitalized. Patient recovered.


Vivactil Side Effects Report #5405004-8
Health Professional from UNITED STATES reported VIVACTIL problem on July 18, 2007. Male patient, 55 years of age, was diagnosed with pain and was treated with VIVACTIL. After drug was administered, patient experienced the following problems/side effects: benign prostatic hyperplasia, condition aggravated, urethral obstruction, urinary retention, . VIVACTIL dosage: 5 MG, TID, ORAL. Patient recovered.

Erbitux Side Effects Report #5760905-6
ERBITUX problem was reported by a Health Professional from UNITED STATES on June 03, 2008. Female patient, 46 years of age, weighting 103.6 lb, was diagnosed with adenocarcinoma of the cervix and was treated with ERBITUX. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, haemoglobin decreased, urethral obstruction, . ERBITUX dosage: START DATE:29FEB08;CYCLE 1, D1 LOADING DOSE 400 MG/M2 IV. SUBSEQUENT DOSES: 250 MG/M2 IV ON D1 + D8. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient recovered.

Nuvaring Side Effects Report #5757814-5
Consumer or non-health professional from FRANCE reported NUVARING problem on May 19, 2008. Female patient, 18 years of age, was treated with NUVARING. After drug was administered, patient experienced the following problems/side effects: pelvic pain, urethral haemorrhage, urethral obstruction, . NUVARING dosage: unknown. Patient recovered.